Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
View Older Stories View More Recent Stories
-
Evolus (EOLS) Announces Proposed 5M Share Common Offering
-
Evolus, Inc. Announces Proposed Public Offering of Common Stock
-
SELLAS Life Sciences Announces Closing of $24.2 Million Public Offering
-
Exotix Capital hires executives to expand fixed income presence
-
Mod-pac Corp (MPAC) Announces Merger with U.S. Well Services LLC
-
Matlin & Partners Acquisition Corporation and U.S. Well Services, LLC Enter Business Combination
-
Thunder Bridge Acquisition, Ltd. Announces Separate Trading of its Class A Ordinary Shares and Warrants, Commencing July 17, 2018
-
Teva Pharma (TEVA) PT Raised to $25 at Cantor Fitzgerald
-
Spero Therapeutics (SPRO) Prices 3.78M Share Offering at $12.50/Sh
-
Spero Therapeutics Announces Pricing of Securities Offering
-
AcelRx Pharma (ACRX) Prices 7.27M Share Offering at $2.75/Sh
-
AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
-
Pre-Open Movers 07/12: (ZGNX) (GLMD) (CA) Higher; (ZN) (ACRX) (AVGO) Lower (more...)
-
SELLAS Life Sciences (SLS) Prices Upsized $24.2 Million Public Offering of Common Stock, Warrants
-
SELLAS Life Sciences Announces Pricing of Upsized $24.2 Million Public Offering
-
Cantor Raises Biohaven (BHVN) PT To $50 After CEO and CFO Meetings
-
After-Hours Stock Movers 7/11: (GLMD) (CA) (WFT) Higher; (ZN) (MYOV) (AVGO) Lower (more...)
-
AcelRx Pharma (ACRX) to Offer Common Stock
-
AcelRx Pharmaceuticals Announces Commencement of Public Offering of Common Stock
-
Cantor Fitzgerald Starts Galmed Pharmaceuticals (GLMD) at Overweight
-
The Ensign Group Inc. (ENSG) PT Raised to $42 at Cantor Fitzgerald
-
Spero Therapeutics (SPRO) Commences 4.5M Common Stock Offering
-
Spero Therapeutics Announces Proposed Offering of Common Stock
-
Cerner (CERN) Partnership With Lumeris is Positive - Cantor
-
Cantor Fitzgerald Reiterates Outperform on Aclaris Therapeutics (ACRS) Following FDA Fast Track Designation
-
Stark Office Suites Expands New York City Footprint
-
Allegro Merger Corp. Announces Closing of $149,500,000 Initial Public Offering
-
Allegro Merger Corp. Announces Closing of $149,500,000 Initial Public Offering
-
Cerner (CERN) PT Raised to $80 at Cantor Fitzgerald
-
WellCare Health Plans (WCG) PT Raised to $275 at Cantor Fitzgerald
-
U.S. yields fall as Wall Street turns lower
-
Efficient Market Advisors Named to Financial Times' 2018 List of Top 300 RIAs
-
Allegro Merger Corp. (ALGRU) Prices 13M Unit IPO at $10/Unit
-
Allegro Merger Corp. Announces Pricing of $130,000,000 Initial Public Offering
-
Allegro Merger Corp. Announces Pricing of $130,000,000 Initial Public Offering
-
Pre-Open Movers 07/02: (ADMP) (VMW) (TSLA) Higher; (MDXG) (MLCO) (LVS) Lower (more...)
-
UPDATE: Cantor Fitzgerald Starts Melinta Therapeutics Inc. (MLNT) at Overweight
-
Mesoblast Enters Into US$50M Financing with Novaquest Capital for Commercial Readiness of Remestemcel-l in the Treatment of Acute Graft Versus Host Disease
-
Cantor Fitzgerald Starts Marinus Pharmaceuticals (MRNS) at Overweight
-
U.S. SEC accuses ex-Cantor Fitzgerald brokers of secret commission sharing
-
Dermira (DERM): FDA Approval of Qbrexza is Positive and Co. is Well Funded Through Launch - Cantor Fitzgerald
-
Accenture plc (ACN) PT Raised to $185 at Cantor Fitzgerald
-
World stocks up slightly Friday, but down for June as U.S. trade policy unnerves investors
-
Thunder Bridge Acquisition, Ltd. Announces Closing of Underwriters' Over-Allotment Option in Connection with its Initial Public Offering
-
Max Sound Asks SEC & FINRA to Accelerate Investigations On Naked Shorting & Failure to Deliver Shares
-
electroCore, Inc. Announces Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering
-
electroCore, Inc. Announces Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering
-
Cantor Fitzgerald Not Worried About Amazon's (AMZN) Entry Into Prescription Market
-
Cantor Fitzgerald Remains Bullish on Arsanis, Inc (ASNS) Following ASN100 Phase 2 Discontinuation
-
Cantor Fitzgerald Reiterates Overweight on Amarin Corp. (AMRN) Following Last Patient Study Visit in REDUCE-IT

